title: Somatosensory input and oromandibular dystonia.
authors.affiliation: Bispebjerg Hospital, Denmark.
authors.forename: E
authors.initials: E
authors.lastname: Møller
authors.forename: M
authors.initials: M
authors.lastname: Bakke
authors.forename: T
authors.initials: T
authors.lastname: Dalager
authors.forename: L M
authors.initials: LM
authors.lastname: Werdelin
authors.forename: M N
authors.initials: MN
authors.lastname: Lonsdale
authors.forename: L
authors.initials: L
authors.lastname: Højgaard
authors.forename: L
authors.initials: L
authors.lastname: Friberg
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D004421:Dystonia / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology*; D004576:Electromyography; D005073:Evoked Potentials, Somatosensory / Q000502:physiology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008336:Mandibular Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology*; D008875:Middle Aged; D009059:Mouth Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology*; D009465:Neuromuscular Agents / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D011626:Pterygoid Muscles / Q000503:physiopathology; D014276:Trigeminal Nerve / Q000502:physiology
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A